Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses

British Journal of Haematology

Volumn 149, Issue 3, 2010, Pages 399-409

  Creutzig, Ursula ^a   Zimmermann, Martin ^b   Dworzak, Michael ^c   Urban, Christian ^d   Henze, Günter ^e   Kremens, Bernhard ^f   Lakomek, Max ^g   Bourquin, Jean Pierre ^h   Stary, Jan ⁱ   Reinhardt, Dirk ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

^g UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^h UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

ⁱ UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Acute promyelocytic leukaemia; Anthracyclines; Cardiotoxicity; Children; Therapy

Indexed keywords

ANTHRACYCLINE; ARSENIC TRIOXIDE; CYTARABINE; CYTOKINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; GEMTUZUMAB OZOGAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; ISOTRETINOIN; MITOXANTRONE; PREDNISOLONE; RETINOIC ACID; TIOGUANINE; TOPOTECAN;

ADULT; ARTICLE; BONE DISEASE; BONE NECROSIS; CANCER RADIOTHERAPY; CARDIOTOXICITY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEMALE; GROWTH DISORDER; HEMATOLOGIC MALIGNANCY; HORMONE DEFICIENCY; HUMAN; INFANT; INFECTION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RISK FACTOR; SALVAGE THERAPY; SECOND CANCER; SIDE EFFECT; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE;

EID: 77950786695     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08107.x     Document Type: Article

References (47)

1. Ades, L., Chevret, S., Raffoux, E., de Botton, S., Guerci, A., Pigneux, A., Stoppa, A.M., Lamy, T., Rigal-Huguet, F., Vekhoff, A., Meyer-Monard, S., Maloisel, F., Deconinck, E., Ferrant, A., Thomas, X., Fegueux, N., Chomienne, C., Dombret, H., Degos, L. Fenaux, P. (2006) Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. Journal of Clinical Oncology, 24, 5703 5710.
2. AML Collaborative Group (1998) A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. British Journal Haematology, 103, 100 109.
3. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. Sultan, C. (1985a) Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Annals of Internal Medicine, 103, 460 462.
4. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. Sultan, C. (1985b) Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine, 103, 626 629.
5. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. Sultan, C. (1991) Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). British Journal Haematology, 78, 325 329.
6. Cheson, B.D., Cassileth, P.A., Head, D.R., Schiffer, C.A., Bennett, J.M., Bloomfield, C.D., Brunning, R., Gale, R.P., Grever, M.R., Keating, M.J., Sawitsky, A., Stass, S., Weinstein, H. Woods, W.G. (1990) Report of the National Cancer Institute-sponsored workshop on definitions and response in acute myeloid leukemia. Journal of Clinical Oncology, 8, 813 819.
7. Creutzig, U., Zimmermann, M., Ritter, J., Henze, G., Graf, N., Löffler, H. Schellong, G. (1999) Definition of a standard-risk group in children with AML. British Journal Haematology, 104, 630 639.
8. Creutzig, U., Ritter, J., Zimmermann, M., Hermann, J., Gadner, H., Blütters-Sawatzki, R., Niemeyer, C.M., Schwabe, D., Selle, B., Boos, J., Kühl, J. Feldges, A. & for the AML-BFM Study Group 2001) Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. Leukemia, 15, 348 354.
9. Creutzig, U., Zimmermann, M., Reinhardt, D., Dworzak, M., Stary, J. Lehrnbecher, T. (2004) Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. Journal of Clinical Oncology, 22, 4384 4393.
10. Creutzig, U., Zimmermann, M., Ritter, J., Reinhardt, D., Hermann, J., Henze, G., Jurgens, H., Kabisch, H., Reiter, A., Riehm, H., Gadner, H. Schellong, G. (2005) Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia, 19, 2030 2042.
11. Creutzig, U., Zimmermann, M., Lehrnbecher, T., Graf, N., Hermann, J., Niemeyer, C.M., Reiter, A., Ritter, J., Dworzak, M., Stary, J. Reinhardt, D. (2006) Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. Journal of Clinical Oncology, 24, 4499 4506.
12. Creutzig, U., Diekamp, S., Zimmermann, M. Reinhardt, D. (2007) Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML. Pediatric Blood Cancer, 48, 651 662.
13. van Dalen, E.C., Raphael, M.F., Caron, H.N. Kremer, L.C. (2009) Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. Cochrane Database Systematic Reviews, 1CD006647.
14. Douer, D., Preston-Martin, S., Chang, E., Nichols, P.W., Watkins, K.J. Levine, A.M. (1996) High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood, 87, 308 313.
15. Estey, E., Garcia-Manero, G., Ferrajoli, A., Faderl, S., Verstovsek, S., Jones, D. Kantarjian, H. (2006) Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood, 107, 3469 3473.
16. Fenaux, P., Le Deley, M.C., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Duarte, M., Daniel, M.T. Bowen, D. (1993) Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood, 82, 3241 3249.
17. Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.-J., Gardin, C., Makhoul, P.C., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., Miguel, J.S., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Maloisel, F., Castaigne, S., Preudhomme, C. Laurent Degos for the European APL Group (1999) A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia. Blood, 94, 1192 1200.
18. Feusner, J. Chow, J. (2009) Isolated central nervous system relapse in acute promyelocytic leukemia (APL) - response. Pediatric Blood Cancer, 53, 237.
19. George, B., Mathews, V., Poonkuzhali, B., Shaji, R.V., Srivastava, A. Chandy, M. (2004) Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience. Leukemia, 18, 1587 1590. (Pubitemid 39386334)
20. Gregory, J. Feusner, J. (2009) Acute promyelocytic leukemia in childhood. Current Oncology Report, 11, 439 445.
21. Iarussi, D., Indolfi, P., Galderisi, M. Bossone, E. (2000) Cardiac toxicity after anthracycline chemotherapy in childhood. Herz, 25, 676 688.
22. Kalbfleisch, J. Prentice, R. (2002) The Statistical Analysis of Failure Time Data. Wiley
23. Kaspers, G., Gibson, B., Grimwade, D., Pession, A., Smith, O. Testi, A.M. (2009) Central nervous system involvement in relapsed acute promyelocytic leukemia. Pediatric Blood Cancer, 53, 36 337.
24. Kremer, L.C., van Dalen, E.C., Offringa, M., Ottenkamp, J. Voute, P.A. (2001) Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. Journal of Clinical Oncology, 19, 191 196.
25. Latagliata, R., Petti, M.C., Fenu, S., Mancini, M., Spiriti, M.A., Breccia, M., Brunetti, G.A., Avvisati, G., Lo, C.F. Mandelli, F. (2002) Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Blood, 99, 822 824.
26. Lengfelder, E., Reichert, A., Schoch, C., Haase, D., Haferlach, T., Loffler, H., Staib, P., Heyll, A., Seifarth, W., Saussele, S., Fonatsch, C., Gassmann, W., Ludwig, W.D., Hochhaus, A., Beelen, D., Aul, C., Sauerland, M.C., Heinecke, A., Hehlmann, R., Wormann, B., Hiddemann, W. Buchner, T. (2000) Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group. Leukemia, 14, 1362 1370.
27. Lengfelder, E., Haferlach, C., Saussele, S., Haferlach, T., Schultheis, B., Schnittger, S., Ludwig, W.D., Staib, P., Aul, C., Gruneisen, A., Kern, W., Reichle, A., Serve, H., Berdel, W.E., Braess, J., Spiekermann, K., Wormann, B., Sauerland, M.C., Heinecke, A., Hiddemann, W., Hehlmann, R. Buchner, T. (2009) High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia, 23, 2248 2258.
28. Lipshultz, S.E., Alvarez, J.A. Scully, R.E. (2008) Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart, 94, 525 533.
29. Mann, G., Reinhardt, D., Ritter, J., Hermann, J., Schmitt, K., Gadner, H. Creutzig, U. (2001) Treatment with all-trans retinoid acid in acute promyelocytic leukemia reduces early deaths in children. Annals of Hematology, 80, 417 422.
30. Maradia, K. Guglin, M. (2009) Pharmacologic prevention of anthracycline-induced cardiomyopathy. Cardiology in Review, 17, 243 252.
31. Ortega, J.J., Madero, L., Martin, G., Verdeguer, A., Garcia, P., Parody, R., Fuster, J., Molines, A., Novo, A., Deben, G., Rodriguez, A., Conde, E., de La, S.J., Allegue, M.J., Capote, F.J., Gonzalez, J.D., Bolufer, P., Gonzalez, M. Sanz, M.A. (2005) Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group. Journal of Clinical Oncology, 23, 7632 7640.
32. Pagano, L. Pulsoni, A. (2002) Second malignancy after treatment of acute promyelocytic leukemia: experience of GIMEMA trials. Gruppo Italiano Malattie Ematologiche dell'Adulto. Blood, 100, 1514 1515.
33. Reinhardt, D., Hempel, G., Fleischhack, G., Schulz, A., Boos, J. Creutzig, U. (2002) [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children]. Klinische Padiatrie, 214, 188 194.
34. Riley, L.C., Hann, I.M., Wheatley, K. Stevens, R.F. (1999) Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party. British Journal Haematology, 106, 436 444.
35. Rovelli, A., Biondi, A., Cantú Rajnoldi, A., Conter, V., Giudici, G., Jankovic, M., Locasciulli, A., Rizzari, C., Romitti, L., Rossi, M.R., Schirò, R., Tosi, S., Uderzo, C. Masera, G. (1992) Microgranular variant of acute promyelocytic leukemia in children. Journal of Clinical Oncology, 10, 1413 1418.
36. Sanz, M.A., Martin, G., Rayon, C., Esteve, J., Gonzalez, M., Diaz-Mediavilla, J., Bolufer, P., Barragan, E., Terol, M.J., Gonzalez, J.D., Colomer, D., Chillon, C., Rivas, C., Gomez, T., Ribera, J.M., Bornstein, R., Roman, J., Calasanz, M.J., Arias, J., Alvarez, C., Ramos, F. Deben, G. (1999) A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group. Blood, 94, 3015 3021.
37. Sanz, M.A., Lo, C.F., Martin, G., Avvisati, G., Rayon, C., Barbui, T., Diaz-Mediavilla, J., Fioritoni, G., Gonzalez, J.D., Liso, V., Esteve, J., Ferrara, F., Bolufer, P., Bernasconi, C., Gonzalez, M., Rodeghiero, F., Colomer, D., Petti, M.C., Ribera, J.M. Mandelli, F. (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood, 96, 1247 1253.
38. Sanz, M.A., Tallman, M.S. Lo-Coco, F. (2005a) Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood, 105, 3019 3025.
39. Sanz, M.A., Fenaux, P. Lo, C.F. (2005b) Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidence. Haematologica, 90, 1231 1235.
40. Sanz, M.A., Montesinos, P., Vellenga, E., Rayon, C., de La, S.J., Parody, R., Bergua, J.M., Leon, A., Negri, S., Gonzalez, M., Rivas, C., Esteve, J., Milone, G., Gonzalez, J.D., Amutio, E., Brunet, S., Garcia-Larana, J., Colomer, D., Calasanz, M.J., Chillon, C., Barragan, E., Bolufer, P. Lowenberg, B. (2008) Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group. Blood, 112, 3130 3134.
41. Sanz, M.A., Grimwade, D., Tallman, M.S., Lowenberg, B., Fenaux, P., Estey, E.H., Naoe, T., Lengfelder, E., Buchner, T., Dohner, H., Burnett, A.K. Lo-Coco, F. (2009) Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 113, 1875 1891.
42. Shen, Z.X., Shi, Z.Z., Fang, J., Gu, B.W., Li, J.M., Zhu, Y.M., Shi, J.Y., Zheng, P.Z., Yan, H., Liu, Y.F., Chen, Y., Shen, Y., Wu, W., Tang, W., Waxman, S., De The, H., Wang, Z.Y., Chen, S.J. Chen, Z. (2004) All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 101, 5328 5335.
43. Soignet, S.L., Frankel, S.R., Douer, D., Tallman, M.S., Kantarjian, H., Calleja, E., Stone, R.M., Kalaycio, M., Scheinberg, D.A., Steinherz, P., Sievers, E.L., Coutre, S., Dahlberg, S., Ellison, R. Warrell, Jr., R.P. (2001) United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. Journal of Clinical Oncology, 19, 3852 3860.
44. Szotkowski, T., Jarosova, M., Faber, E., Hubacek, J., Hlusi, A., Papajik, T., Pikalova, Z., Kucerova, L., Holzerova, M., Budikova, M., Buriankova, E., Plachy, R., Potomkova, J., Klusova, N., Szotkowska, R. Indrak, K. (2009) Precursor T-lymphoblastic lymphoma as a secondary malignancy in a young patient after successful treatment of acute promyelocytic leukemia. Onkologie, 32, 513 515.
45. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Woods, W.G., Ogden, A., Weinstein, H., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. Wiernik, P.H. (2002) All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood, 100, 4298 4302.
46. Testi, A.M., Biondi, A., Lo, C.F., Moleti, M.L., Giona, F., Vignetti, M., Menna, G., Locatelli, F., Pession, A., Barisone, E., De Rossi, G., Diverio, D., Micalizzi, C., Arico, M., Basso, G., Foa, R. Mandelli, F. (2005) GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood, 106, 447 453.
47. Wang, Z.Y. Chen, Z. (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood, 111, 2505 2515.